Cantourage GmbH and Clever Leaves Holdings Inc. have continued to intensify their strategic partnership for the distribution of medical cannabis flowers throughout Germany.
Following the successful introduction of Clever Leaves' IQANNA No 7 medical cannabis flowers to the German pharmaceutical market, Cantourage and Clever Leaves launched the 'IQANNA No 10'-branded Wappa cultivar. The dried flower product is cultivated in Clever Leaves' facility in Portugal, where the company operates approximately 25,000 m2 of actively producing GACP-certified greenhouses.
Cantourage processes the Wappa-based IQANNA No 10 cannabis flowers, transforming them into medical cannabis products with one of the highest THC levels available in German pharmacies. Cantourage's and Clever Leaves' expanded partnership further increases the range of international, high-quality medical cannabis products that Cantourage has been making available to the EU market.
Cantourage manufactures and distributes medical cannabis products sourced from around the world and makes them available to patients in Germany and Europe. IQANNA No 10 is the second Clever Leaves product made available to patients in Germany, with further products under the IQANNA brand to be introduced in Germany in the coming weeks.
Philip Schetter, CEO of Cantourage, commented: "Today's launch of the IQANNA No 10 medical cannabis flowers is an important step in our intensified partnership with Clever Leaves and further improves the already growing range of medical cannabis products available to German pharmacies and patients. Clever Leaves is a large-scale and experienced multinational operator with sustainable operations and excellent quality products from countries with exceptional natural growing conditions. We very much look forward to further deepening our partnership and making further Clever Leaves products available to German patients, among whom we know that demand levels are very high".
Caroline Kliess, Managing Director of Clever Leaves Germany GmbH, added: "We are excited to extend our partnership with Cantourage and launch our next medical cannabis flower product under the IQANNA brand.
Andres Fajardo, CEO of Clever Leaves, stated: "Broadening distribution is an important goal, and we are delighted that the successful strategic partnership with Cantourage has allowed us to take this next step in bringing our high-quality products and brands into the European market. We are excited about the opportunity to play a role in meeting the needs of the quickly growing key markets of Germany and Europe".
For more information:
Cantourage 
www.cantourage.com